Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$67.25
+0.2%
$66.58
$37.64
$70.81
$1.42B0.8134,627 shs108,735 shs
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
$0.93
+1.1%
$0.77
$0.41
$2.05
$92.04M0.92745,459 shs323,290 shs
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
$1.67
-3.5%
$2.37
$1.40
$9.45
$10.99M1.1552,239 shs81,114 shs
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
$35.39
+4.8%
$37.59
$2.03
$14.36
$332.60M1.1150,104 shs78,640 shs
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
$1.24
-2.4%
$1.39
$0.07
$1.45
$603.04M1.77141,517 shs161,724 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
+0.89%+3.33%+0.58%+21.09%+75.13%
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
+2.10%+13.87%+20.78%+34.99%-23.51%
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
+4.55%+8.49%-9.21%-53.13%-70.19%
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
+2.64%+18.48%-24.35%+15.05%+101.08%
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
0.00%-5.22%-8.63%-42.01%-57.53%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
4.5667 of 5 stars
2.53.00.03.32.63.33.1
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
2.624 of 5 stars
3.53.00.00.03.11.70.6
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
0.8764 of 5 stars
0.02.00.04.60.64.20.0
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
3.00
Buy$80.0018.96% Upside
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
3.00
Buy$4.67401.68% Upside
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
N/AN/AN/AN/A
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
N/AN/A$30.00-15.23% Downside
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/A

Current Analyst Ratings

Latest NLTX, MTEM, HOOK, ANIP, and WIZP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.50 ➝ $5.00
4/23/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$77.00
3/25/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$5.00
3/25/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.50
3/15/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$80.00
3/5/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$70.00 ➝ $77.00
3/4/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$73.00 ➝ $83.00
3/1/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$72.00 ➝ $80.00
2/16/2024
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$70.00 ➝ $72.00
(Data available from 5/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$486.82M2.91$6.49 per share10.37$21.13 per share3.18
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
$20.13M4.57N/AN/A$0.91 per share1.02
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
$57.31M0.19N/AN/A$0.78 per share2.14
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
N/AN/AN/AN/A$11.08 per shareN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/A$0.03 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$18.78M$0.8480.0616.24N/A3.86%18.06%8.38%5/10/2024 (Confirmed)
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
-$81.58M-$0.88N/AN/AN/A-405.28%-72.30%-40.51%5/9/2024 (Estimated)
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
-$8.12M-$1.55N/AN/AN/A-14.18%-9,335.53%-20.51%5/20/2024 (Estimated)
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
-$57.56M-$3.11N/AN/AN/A-37.22%-30.91%N/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
-$3.45M-$0.33N/AN/AN/AN/AN/A-85.32%N/A

Latest NLTX, MTEM, HOOK, ANIP, and WIZP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/10/2024N/A
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$0.9750N/A-$0.9750N/AN/AN/A  
3/29/2024Q4 2023
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
-$2.10-$0.73+$1.37-$0.73N/A$7.02 million
3/22/2024Q4 2023
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
-$0.20-$0.11+$0.09N/A$3.60 million$7.41 million
2/29/2024Q4 2023
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$0.58$0.78+$0.20$1.52$123.02 million$131.65 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
N/AN/AN/AN/AN/A
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
N/AN/AN/AN/AN/A
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
N/AN/AN/AN/AN/A
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
N/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
0.66
3.57
2.81
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
N/A
3.50
3.50
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
N/A
0.97
0.97
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
N/A
15.33
15.33
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/A
1.13
1.13

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
64221.08 million18.40 millionOptionable
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
5698.95 million93.19 millionOptionable
Molecular Templates, Inc. stock logo
MTEM
Molecular Templates
626.58 million5.35 millionNo Data
Neoleukin Therapeutics, Inc. stock logo
NLTX
Neoleukin Therapeutics
79.40 million9.25 millionOptionable
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
2486.32 millionN/ANot Optionable

NLTX, MTEM, HOOK, ANIP, and WIZP Headlines

SourceHeadline
Mawson Infrastructure Group adds new customer at Midland bitcoin facilityMawson Infrastructure Group adds new customer at Midland bitcoin facility
bizjournals.com - December 20 at 11:39 AM
Mawson announces agreement for half of Midland bitcoin facility capacityMawson announces agreement for half of Midland bitcoin facility capacity
bizjournals.com - October 19 at 5:32 PM
Mawson Infrastructure reports BTC production of 69 in July, down 3% M/MMawson Infrastructure reports BTC production of 69 in July, down 3% M/M
seekingalpha.com - August 24 at 6:28 PM
H.C. Wainwright Sticks to Its Buy Rating for Mawson Infrastructure Group (MIGI)H.C. Wainwright Sticks to Its Buy Rating for Mawson Infrastructure Group (MIGI)
markets.businessinsider.com - August 24 at 7:44 AM
Mawson Infrastructure Group Inc. Invites Submission of Indication of Interest for its BTC Hosting and HPC Co-location ServicesMawson Infrastructure Group Inc. Invites Submission of Indication of Interest for its BTC Hosting and HPC Co-location Services
technews.tmcnet.com - July 25 at 10:20 AM
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for June 2023Mawson Infrastructure Group Inc. Announces Monthly Operational Update for June 2023
businesswire.com - July 19 at 10:01 AM
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for May 2023Mawson Infrastructure Group Inc. Announces Monthly Operational Update for May 2023
technews.tmcnet.com - June 14 at 10:10 AM
Mawson Infrastructure Group names new president, CEOMawson Infrastructure Group names new president, CEO
bizjournals.com - May 22 at 12:56 PM
With Significant Increases In Megawatt Capacity And Bitcoin Production, Mawson Infrastructure Group (NASDAQ: MIGI) May Attract More Bitcoin Mining InvestorsWith Significant Increases In Megawatt Capacity And Bitcoin Production, Mawson Infrastructure Group (NASDAQ: MIGI) May Attract More Bitcoin Mining Investors
msn.com - April 11 at 10:13 AM
Earnings Outlook For Mawson InfrastructureEarnings Outlook For Mawson Infrastructure
msn.com - November 12 at 8:40 PM
Bitcoin Miner CleanSpark Buys Mawson Site as Consolidation RisesBitcoin Miner CleanSpark Buys Mawson Site as Consolidation Rises
finance.yahoo.com - September 11 at 12:26 AM
Mawson Infrastructure Group Inc. To Sell Sandersville, Georgia Bitcoin Mining Facility including 6468 ASIC Bitcoin Miners To CleanSpark, Inc. For Up To $42.5 MillionMawson Infrastructure Group Inc. To Sell Sandersville, Georgia Bitcoin Mining Facility including 6468 ASIC Bitcoin Miners To CleanSpark, Inc. For Up To $42.5 Million
benzinga.com - September 9 at 10:20 AM
Why Bitcoin- And Ethereum-Related Stock CleanSpark Is Rising TodayWhy Bitcoin- And Ethereum-Related Stock CleanSpark Is Rising Today
benzinga.com - September 9 at 10:20 AM
Mawson Infrastructure Group Inc. Announces July 2022 Bitcoin Self-Mining, Hosting Co-location, Energy Demand Response and Operational UpdateMawson Infrastructure Group Inc. Announces July 2022 Bitcoin Self-Mining, Hosting Co-location, Energy Demand Response and Operational Update
finance.yahoo.com - August 25 at 10:24 AM
Mawson Infrastructure Group Inc. Schedules Second Quarter Results Webcast for 5:30 p.m. ET on August 22, 2022Mawson Infrastructure Group Inc. Schedules Second Quarter Results Webcast for 5:30 p.m. ET on August 22, 2022
benzinga.com - August 18 at 9:55 AM
Bitcoin Miner Mawson Infrastructure Produced 185 Bitcoin In Record-Breaking MayBitcoin Miner Mawson Infrastructure Produced 185 Bitcoin In Record-Breaking May
bitcoinmagazine.com - June 16 at 3:23 PM
Mawson to Develop New Bitcoin Mining Site in TexasMawson to Develop New Bitcoin Mining Site in Texas
finance.yahoo.com - May 17 at 2:50 AM
Mawson Infrastructure Group Inc. Announces New 120 Megawatt Bitcoin Mining Facility in Texas, USAMawson Infrastructure Group Inc. Announces New 120 Megawatt Bitcoin Mining Facility in Texas, USA
tmcnet.com - May 16 at 9:34 AM
Texas Pacific Land Corporation, Mawson Infrastructure Group Inc., and JAI Energy Announce New Bitcoin Mining Venture in West TexasTexas Pacific Land Corporation, Mawson Infrastructure Group Inc., and JAI Energy Announce New Bitcoin Mining Venture in West Texas
tmcnet.com - May 16 at 9:34 AM
Mawson Infrastructure Group discusses Q3 highlights including Quinbrook renewable energy partnershipMawson Infrastructure Group discusses Q3 highlights including Quinbrook renewable energy partnership
proactiveinvestors.com - December 14 at 11:45 PM
Audacious Secures $20M Funding & Closes $3.1M Non-Brokered Private Placement TrancheAudacious Secures $20M Funding & Closes $3.1M Non-Brokered Private Placement Tranche
benzinga.com - December 11 at 11:01 PM
Essential Investment? This REIT Believes in Cannabis-Related Real EstateEssential Investment? This REIT Believes in Cannabis-Related Real Estate
benzinga.com - December 9 at 6:25 PM
South Dakotas Supreme Strikes Down Recreational Cannabis Vote, Overturning Peoples WillSouth Dakota's Supreme Strikes Down Recreational Cannabis Vote, Overturning People's Will
benzinga.com - November 28 at 6:55 PM
10 Weed Strains For People Who Like Cheese10 Weed Strains For People Who Like Cheese
benzinga.com - November 8 at 12:11 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ANI Pharmaceuticals logo

ANI Pharmaceuticals

NASDAQ:ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Hookipa Pharma logo

Hookipa Pharma

NASDAQ:HOOK
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Molecular Templates logo

Molecular Templates

NASDAQ:MTEM
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Neoleukin Therapeutics logo

Neoleukin Therapeutics

NASDAQ:NLTX
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Mawson Infrastructure Group logo

Mawson Infrastructure Group

OTCMKTS:WIZP
Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company is headquartered in North Sydney, Australia.